---
id: aecopd-antibiotics_276
category: clinical-syndromes
tags: [COPD, AECOPD, exacerbation, antibiotics, GOLD-criteria]
deck: Infectious Diseases
created: 2025-01-11
modified: 2025-01-11
---

## AECOPD: Antibiotic Indications per GOLD Guidelines

**Q:** When are antibiotics indicated for acute exacerbations of COPD (AECOPD) according to GOLD guidelines?

**A:**

**GOLD Antibiotic Indications:**

1. **All 3 cardinal symptoms present:**
   - ↑ Dyspnea
   - ↑ Sputum volume
   - ↑ **Sputum purulence**

2. **2 of 3 cardinal symptoms IF purulence is one:**
   - Purulence + (dyspnea OR volume)

3. **Mechanical ventilation required**

**Etiology:**
- **Bacterial (~50%)**: *H. influenzae, S. pneumoniae, M. catarrhalis*
- **Viral (~30-50%)**: Rhinovirus, influenza, RSV
- **Co-infection (20%)**: Bacterial + viral
- **Non-infectious (30%)**: Pollution, environmental irritants

**Biomarkers for Antibiotic Decision:**
- **Procalcitonin (PCT) <0.1 ng/mL**: Antibiotics likely NOT beneficial
- **CRP/PCT elevation**: Suggests bacterial etiology

**First-Line Antibiotics:**
- **No recent antibiotics (<3 mo)**: Amoxicillin-clavulanate 875/125 mg BID × 5 days
- **Recent antibiotics or risk factors**: Respiratory fluoroquinolone (levofloxacin 750 mg daily × 5 days)

**Pearl:** Sputum purulence is the key predictor of bacterial infection and antibiotic benefit.

**Media:**

**Sources:** [GOLD Guidelines], [Johns Hopkins ABX Guide AECOPD], [PMC6517133 - Cochrane Antibiotics for AECOPD], [BMC Pulm Med - Biomarkers for AECOPD 2022]
